DK1377294T3 - Anvendelse af neuroaktive stoffer til behandling af Parkinson's sygdom og farmaceutisk kombination - Google Patents

Anvendelse af neuroaktive stoffer til behandling af Parkinson's sygdom og farmaceutisk kombination

Info

Publication number
DK1377294T3
DK1377294T3 DK02724212T DK02724212T DK1377294T3 DK 1377294 T3 DK1377294 T3 DK 1377294T3 DK 02724212 T DK02724212 T DK 02724212T DK 02724212 T DK02724212 T DK 02724212T DK 1377294 T3 DK1377294 T3 DK 1377294T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical combination
disease
treat parkinson
neuroactive agents
treatment
Prior art date
Application number
DK02724212T
Other languages
English (en)
Inventor
Ralph Dawirs
Original Assignee
Ralph Dawirs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ralph Dawirs filed Critical Ralph Dawirs
Application granted granted Critical
Publication of DK1377294T3 publication Critical patent/DK1377294T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4515—Non condensed piperidines, e.g. piperocaine having a butyrophenone group in position 1, e.g. haloperidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK02724212T 2001-03-09 2002-03-08 Anvendelse af neuroaktive stoffer til behandling af Parkinson's sygdom og farmaceutisk kombination DK1377294T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10111486A DE10111486A1 (de) 2001-03-09 2001-03-09 Verwendung einer oder mehrerer neuroaktiver Substanzen zur Behandlung der Parkinsonschen Krankheit

Publications (1)

Publication Number Publication Date
DK1377294T3 true DK1377294T3 (da) 2006-07-24

Family

ID=7676934

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02724212T DK1377294T3 (da) 2001-03-09 2002-03-08 Anvendelse af neuroaktive stoffer til behandling af Parkinson's sygdom og farmaceutisk kombination

Country Status (11)

Country Link
US (1) US20040147613A1 (da)
EP (1) EP1377294B1 (da)
JP (1) JP2004526723A (da)
KR (1) KR20040007464A (da)
AT (1) ATE320810T1 (da)
AU (1) AU2002254935A1 (da)
DE (2) DE10111486A1 (da)
DK (1) DK1377294T3 (da)
ES (1) ES2261663T3 (da)
PT (1) PT1377294E (da)
WO (1) WO2002072094A2 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8877802B2 (en) * 2005-07-28 2014-11-04 Duke Univerity Antiparkinsonian action of phenylisopropylamines
KR20120103557A (ko) * 2009-07-31 2012-09-19 클레라 아이엔씨. 파킨슨씨병 치료용 조성물 및 치료방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU77658A1 (de) * 1977-06-30 1979-03-26 Byk Gulden Lomberg Chem Fab Alkylsubstituierte piperidin-n-oxide,verfahren zu ihrer herstellung,ihre verwendung und sie enthaltende arzneimittel
US5602150A (en) * 1992-10-02 1997-02-11 Research Foundation For Mental Hygiene, Inc. Treatment of central nervous system disorders associated with psychotic behavior and dementia with a combination of neuroleptic drugs and taurine, or derivatives thereof, to prevent the development of tardive dyskinesia
WO1996013503A1 (en) * 1993-01-06 1996-05-09 Neurogen Corporation Certain tricyclic substituted diazabicyclo[3.2.1] octane derivatives
CA2195239A1 (en) * 1994-07-15 1996-02-01 David E. Nichols Optically active isomers of dihydrexidine and its substituted analogs
JP2001506580A (ja) * 1996-12-24 2001-05-22 藤沢薬品工業株式会社 アミノピペラジン誘導体の新規用途
AU746153B2 (en) * 1997-12-31 2002-04-18 Direct Therapeutics, Inc. Method for tissue perfusion
IL148175A0 (en) * 1999-08-18 2002-09-12 Gen Hospital Corp Methods, compositions and kits for promoting recovery from damage to the central nervous system

Also Published As

Publication number Publication date
EP1377294A2 (de) 2004-01-07
WO2002072094A2 (de) 2002-09-19
ATE320810T1 (de) 2006-04-15
ES2261663T3 (es) 2006-11-16
US20040147613A1 (en) 2004-07-29
DE10111486A1 (de) 2002-10-02
KR20040007464A (ko) 2004-01-24
EP1377294B1 (de) 2006-03-22
WO2002072094A3 (de) 2003-01-23
AU2002254935A1 (en) 2002-09-24
DE50206139D1 (de) 2006-05-11
JP2004526723A (ja) 2004-09-02
PT1377294E (pt) 2006-08-31

Similar Documents

Publication Publication Date Title
BR0308243A (pt) Composto, formulação farmacêutica, e, métodos de tratar diabetes, doença de alzheimer, e de inibir gsk-3 em um mamìfero
DK2527315T3 (da) Forbindelser, præparater og fremgangsmåder til behandling af amyloide sygdomme og synukleinopatier, såsom Alzheimers sygdom, type 2-diabetes og Parkinsons sygdom
DK1328269T3 (da) Kombination af en CB1-receptorantagonist og sibutramin til behandling af fedme
WO2005053795A3 (en) Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
IS6922A (is) Heterófjölhringjaefnasambönd og notkun þeirra semmetabótrópísk mótlyf gegn glútamat viðtökum
DE50203788D1 (de) Pharmazeutische zusammensetzung zur ophtalmologischen und rhinologischen anwendung
BR9812837A (pt) Processo para fazer um composto, e, composto
EA200600971A1 (ru) Применение замещённых 2 - аминотетралинов для профилактического лечения болезни паркинсона
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
BRPI0508051A (pt) derivados de heteroarilaminopirazol utilizáveis para o tratamento de diabetes
TW200736255A (en) 5-(Substituted)-pyrazolopiperidines
DK1670903T3 (da) Behandling af neurodegenerative sygdomme
DE60025639D1 (de) Substituierte diazepan
PT1355906E (pt) Derivados de 2h-1-benzopirano processos para a sua preparacao e as suas composicoes farmaceuticas
DK0996435T3 (da) Aminosyrederivater anvendelige til behandling af slagtilfælde
DK1161239T3 (da) 3- cyclopropylmethoxy-4-difluormethoxy-N-(3,5-dichlorpyrid-4-yl)benzamid til behandling af dissemineret sklerose
MA26397A1 (fr) Protege-orteils, particulierement pour chaussures de securite.
DE60133385D1 (de) (+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol oder prodrug davon zur behandlung von demenzsymptomen oder kognitiven störungen
BR0206687A (pt) Método para prevenir e tratar dores viscerais e distúrbios gastrointestinais
HRP20040186B1 (en) Use of lhrh-antagonists for the improvement of t-cell mediated immunity
PT1377294E (pt) A utilizacao de substancias neuroactivas e a sua combinacao para o tratamento da doenca de parkinson.
DE60311284D1 (de) 4-(3,5-dicyanophenoxy)pyrazol-derivate zur verwendung als reverse transkriptase modulatoren zur behandlung von u.a. hiv
TW200505435A (en) Treatment of ocular disorders
BR0210678A (pt) Carbamatos de 2-heterocìclicos-1,2-etanodióis
DK1366033T3 (da) Kemiske forbindelser